Cargando…
TRAP1 and SORCIN cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma (CRC)
Autores principales: | Landriscina, Matteo, Maddalena, Francesca, Laudiero, Gabriella, Amoroso, Maria R, Piscazzi, Annamaria, Lombardi, Valentina, Fersini, Alberto, Esposito, Franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255034/ |
Ejemplares similares
-
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: A novel strategy for human BRAF-driven colorectal carcinoma
por: Condelli, Valentina, et al.
Publicado: (2015) -
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation
por: Bruno, Giuseppina, et al.
Publicado: (2022) -
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas
por: Maddalena, Francesca, et al.
Publicado: (2020) -
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
por: Crispo, Fabiana, et al.
Publicado: (2020) -
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma
por: Maddalena, Francesca, et al.
Publicado: (2017)